Regenxbio Inc. (RGNX) PT Raised to $75 at Chardan Capital Markets

September 5, 2017 1:51 AM EDT


Send to a Friend

Chardan Capital Markets raised its price target on Regenxbio Inc. (NASDAQ: RGNX) to $75.00 (from $55.00) while maintaining a Buy …

This is a premium only article. To continue reading this article and more like it please sign-in or upgrade to Premium below (Free Trial)

Leave a Reply

Your email address will not be published. Required fields are marked *


13 − six =